Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Therapy decisions are informed by clinical evaluation and, when required, laboratory data to ensure antioxidant support aligns with the individuals physiological demands rather than being applied generically
Primary antibodies targeted FOXO4, Leydig cell markers (StAR, CYP11A1, 3-HSD), spermatogenesis markers (PCNA, PLZF, UCHL1, SCP3), and senescence/apoptosis markers (Ser15-phospho-p53)
doi: 10.1016/j.cca.2024.119857 284 ZhangJZhangYWangJXiaYZhangJChenL
The weight of any such item can be found on its detail page
Pharmacogenomics 11(3):349356
US$ 28.38
US$ 29.70
US$ 27.38
US$ 28.47
US$ 27.66
US$ 28.11
US$ 27.55
US$ 29.97
US$ 28.80
US$ 26.14
US$ 27.79
